{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:55:07Z","timestamp":1793382907106,"version":"4.5.0"},"reference-count":78,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Institute On Drug Abuse of the National Institutes of Health","award":["U01DA051658 (MP)"],"award-info":[{"award-number":["U01DA051658 (MP)"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2122507","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T19:05:11Z","timestamp":1664910311000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":32,"title":["Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6934-4050","authenticated-orcid":false,"given":"Dustin","family":"Hicks","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3395-6776","authenticated-orcid":false,"given":"Carly","family":"Baehr","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-9111","authenticated-orcid":false,"given":"Pedro","family":"Silva-Ortiz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2588-0900","authenticated-orcid":false,"given":"Aaron","family":"Khaimraj","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4550-841X","authenticated-orcid":false,"given":"Diego","family":"Luengas","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3496-2104","authenticated-orcid":false,"given":"Fatima A.","family":"Hamid","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1036-0184","authenticated-orcid":false,"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA"},{"name":"Center for Immunology, University of Minnesota, Minneapolis, MN, USA"},{"name":"School of Medicine, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"e_1_3_6_3_1","article-title":"Overdose death rates involving opioids, by type, United States, 1999-2019","volume":"2","author":"Centres for Disease Control and Prevention","year":"2021","unstructured":"Centres for Disease Control and Prevention. Overdose death rates involving opioids, by type, United States, 1999-2019. National Center Injury Prev Control. 2021;2.","journal-title":"National Center Injury Prev Control"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6910a4"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108314"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2021.1948558"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.10.016"},{"key":"e_1_3_6_8_1","article-title":"The drug overdose toll in 2020 and near-term actions for addressing it","author":"Baumgartner JC","year":"2021","unstructured":"Baumgartner JC, Radley DC. The drug overdose toll in 2020 and near-term actions for addressing it. The Commonwealth Fund; 2021.","journal-title":"The Commonwealth Fund"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-85-6-765"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042098617744161"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/85.4.533"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2003.009613"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-019-0195-4"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.258566"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106279"},{"key":"e_1_3_6_16_1","first-page":"84","article-title":"The pharmacokinetics and pharmacodynamics of monoclonal antibodies-mechanistic modeling applied to drug development","volume":"10","author":"Mould DR","year":"2007","unstructured":"Mould DR, Sweeney KR. The pharmacokinetics and pharmacodynamics of monoclonal antibodies-mechanistic modeling applied to drug development. Curr Opin Drug Discovery Dev. 2007;10:84\u201396.","journal-title":"Curr Opin Drug Discovery Dev"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2009.04.011"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108653"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01042"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.120.000124"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.1991552"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.9b04872"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.04.117"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2006.01.008"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.27620"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.4161\/19420862.2014.976431"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.1.4.365-372.1994"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2005.01.001"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.2.3.11641"},{"key":"e_1_3_6_30_1","unstructured":"The Antibody Society. Therapeutic monoclonal antibodies approved or in review in the European Union or the United States. 2022. http:\/\/www.antibodysociety.org\/resources\/approved-antibodies."},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218717"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c00820"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00260"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot5636"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1810576116"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2016.08.019"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.221463198"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1631117"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi951526c"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3549(15)00185-9"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.001048"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/02648725.2013.801235"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1159\/000478077"},{"key":"e_1_3_6_44_1","first-page":"132","article-title":"IMGT Unique Numbering","volume":"7","author":"Lefranc M-P","year":"1999","unstructured":"Lefranc M-P. IMGT Unique Numbering. The Immunologist. 1999;7:132\u201336.","journal-title":"The Immunologist"},{"key":"e_1_3_6_45_1","volume-title":"Sequences of proteins of immunological interest","author":"Kabat EA","year":"1992","unstructured":"Kabat EA, Te Wu T, Perry HM, Foeller C, Gottesman KS. Sequences of proteins of immunological interest. Darby: DIANE Publishing; 1992."},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1997.1354"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.23.9268"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks480"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1553476"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2014.04.011"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.28693"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1177\/108705710100600609"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja8049063"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2020.08.019"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2020.1743053"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2017.09.027"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1016694"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20727"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1189048"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.02.042"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2019.112676"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1616408114"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14860"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13462"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/jctb.4850"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2019.08.018"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1290753"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2018.1548233"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2017.1368602"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbab027"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2016.05.029"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.7748\/ns.29.4.52.e9183"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2019.03.008"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpclett.1c03669"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.9b03779"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.03.017"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01296"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.261180"},{"key":"e_1_3_6_79_1","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2011-2016","volume":"67","author":"Hedegaard H","year":"2018","unstructured":"Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011-2016. Natl Vital Stat Rep. 2018;67:1\u201314.","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108722"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2122507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:45:34Z","timestamp":1737049534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2122507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2122507"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2122507","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2122507"}}